Ascent Industries (CSE:ASNT) COO Reid Parr was interviewed by Proactive Investors. He provided a status update for the Agrima Labs, Botanicals and Meadows campuses in British Columbia. The Agrima Botanicals facility is currently operating at full capacity and is harvesting crops on a weekly basis, while their Meadows and Lab facilities are currently under review with Health Canada and will be completing phase one construction by the end of 2018. Agrima Labs will be their e-commerce and global distribution centre as they have their dealer’s license which allows them to distribute cannabis throughout Canada and the world.
Parr also provided an update on the status on the company’s holdings in Nevada and Oregon. They have been licensed as producer-processors and distributors in Oregon and Nevada. They are also currently selling over 40 of their products in 130 dispensaries in both states. Additionally, Parr discussed the company’s expansion plans into Denmark. Denmark provides a highly respected healthcare industry, but allows more cannabis derived products than Germany currently does.
“We’re very excited to be expanding into Europe,” said Parr. “We’ve secured a Level 10 GMP pharmaceutical distribution facility. We’re in the application phase for a controlled drug license, a dealers license and medical cannabis pilot program license.”
Ascent has defined itself in part as a research company. They’ve been conducting research for the past five years in house and with Simon Fraser University. The company focuses on five areas of research: genetics, product development, preclinical research, production and manufacturing optimization and market research.
To view the interview, click here.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact firstname.lastname@example.org, or